Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Digital Cognitive Training in Older Adults

11. November 2026 aktualisiert von: Jihye Jung

Effect of a Physical Acticity-Integrated Digital Cognitive Training Program on Cognitive Function and Physical Performance in Community-Dwelling Older Adults

The purpose of this clinical study is to evaluate the effects of a digital cognitive training program combined with physical activity on the cognitive and physical functions of community-dwelling older adults. For older adults, maintaining both mental and physical health is essential for overall well-being. This study hypothesizes that combining tablet-based brain exercises with short, physical activities will help improve participants' memory, thinking skills, and physical abilities, such as balance and walking.

Researchers aim to enroll approximately 35 community-dwelling older adults who are 65 years of age or older and capable of walking. Participants will be randomly assigned to one of two groups:

  1. Standard Intervention Group: Participants will attend a 50-minute session once a week for 10 weeks. During each session, they will use a tablet device for cognitive training focused on memory, attention, and executive functions. This training will be paused three times per session for about 3 minutes each to perform low-intensity, physical activities to music.
  2. Extended Intervention Group: Participants will participate in the same 10-week digital cognitive training and physical activity program as the standard group. In addition, they will receive additional home-based cognitive activities to complete once a week.

To measure the effectiveness of the program, researchers will assess all participants before the program starts and after the 10-week program ends. Assessments will evaluate cognitive function, including memory and attention, as well as physical functions, such as grip strength, leg strength, balance, walking speed, and muscle mass.

Studienübersicht

Status

Noch keine Rekrutierung

Bedingungen

Intervention / Behandlung

Studientyp

Interventionell

Einschreibung (Geschätzt)

35

Phase

  • Unzutreffend

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

65 Jahre und älter (Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Community-dwelling older adults aged 65 years or older.
  • Able to understand the purpose of the study and voluntarily consent to participate.
  • Cognitively intact or presenting with mild subjective memory complaints without a diagnosis of dementia (e.g., MoCA score ≥ 23 or MMSE score ≥ 24).
  • Able to walk independently without assistance (with or without assistive devices).
  • Able to understand instructions and perform cognitive and physical training programs using digital devices.

Exclusion Criteria:

  • Diagnosis of dementia or severe cognitive impairment.
  • Severe visual or hearing impairment that interferes with participating in digital training or assessment.
  • Acute or chronic neurological/musculoskeletal disorders that limit physical training (e.g., recent stroke, severe osteoarthritis).
  • History of severe cardiovascular disease or unmanaged hypertension/diabetes.
  • Current participation in other interventional clinical trials or similar cognitive/physical training programs.
  • Inability to follow study instructions due to severe psychiatric illness or communication difficulties.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Verhütung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Aktiver Komparator: Standard Intervention Group

Participants will receive a 50-minute session consisting of tablet-based digital cognitive training combined with physical activities once a week for 10 weeks.

A 10-week program where participants attend a 50-minute session once a week. Each session involves tablet-based digital cognitive training (focusing on memory, attention, and executive functions) combined with three 3-minute bouts of low-intensity, physical activities.

Experimental: Extended Intervention Group

Participants will receive the same 10-week program as the Standard Intervention Group (tablet-based digital cognitive training and seated physical activities). In addition, they will receive home-based cognitive activities to complete once a week.

A 10-week program combining a once-weekly 50-minute center-based session (tablet-based cognitive training and seated physical activities) with additional home-based cognitive activities to be completed once a week.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
The Korean Version of Montreal Cognitive Assessment (MoCA-K)
Zeitfenster: Baseline and 10 weeks

Cognitive function will be assessed using the Korean version of the Montreal Cognitive Assessment (MoCA-K). Total scores range from 0 to 30, where higher scores indicate better cognitive performance.

Baseline and 10 weeks

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
The Short Physical Performance Battery (SPPB).
Zeitfenster: Baseline and 10 weeks

Overall physical performance will be assessed using the Short Physical Performance Battery (SPPB). The SPPB evaluates lower extremity function through three components: standing balance, gait speed, and a 5-repetition chair stand test. Each component is scored from 0 to 4, yielding a total score ranging from 0 to 12. Higher scores indicate better physical function.

Baseline and 10 weeks
Change in Grip Strength
Zeitfenster: Baseline and 10 weeks

Handgrip strength will be measured using a hand dynamometer. Results are recorded in kilograms (kg), where higher values indicate greater upper body muscle strength.

Baseline and 10 weeks
Change in Lower Extremity Strength
Zeitfenster: Baseline and 10 weeks

Lower body strength will be assessed using the Five-times Sit-to-Stand test. Scores indicate the seconds of stands completed in 5 times, where a higher number indicates better lower extremity strength.

Baseline and 10 weeks
Change in Dynamic Balance
Zeitfenster: Baseline and 10 weeks

Dynamic balance will be assessed using the Timed Up and Go (TUG) test. Results are measured in seconds, where a lower time indicates better mobility and dynamic balance.

Baseline and 10 weeks
Change in Static Balance
Zeitfenster: Baseline and 10 weeks

Static balance will be assessed using the Balancia software by measuring COP sway path length under the eyes open and closed condition. Results are recorded in centimeters (cm), where lower values indicate better postural stability.

Baseline and 10 weeks
Change in Gait velocity
Zeitfenster: Baseline and 10 weeks

Gait velocity will be assessed using the GAITRite electronic walkway system. Results are measured in centimeters per second (cm/s), where higher values indicate better walking performance.

Baseline and 10 weeks
Change in Gait cadence
Zeitfenster: Baseline and 10 weeks

Gait cadence will be assessed using the GAITRite electronic walkway system. Results are measured in steps per minute (steps/min), where higher values indicate better gait rhythm and coordination.

Baseline and 10 weeks
Change in Step Length
Zeitfenster: Baseline and 10 weeks

Step length will be assessed using the GAITRite electronic walkway system. Results are measured in centimeters (cm), where higher values indicate better gait efficiency.

Baseline and 10 weeks
Change in Stride Length
Zeitfenster: Baseline and 10 weeks

Stride length will be assessed using the GAITRite electronic walkway system. Results are measured in centimeters (cm), where higher values indicate better mobility.

Baseline and 10 weeks
Change in Skeletal Muscle Mass Index (SMI)
Zeitfenster: Baseline and 10 weeks

Skeletal Muscle Mass Index (SMI) will be assessed using a Bioelectrical Impedance Analysis (BIA) device (InBody BWA). SMI is reported in kg/m², where higher values indicate greater skeletal muscle mass.

Baseline and 10 weeks
Change in Subjective Memory Complaints (SMCQ-K)
Zeitfenster: Baseline and 10 weeks

Subjective memory complaints will be assessed using the Subjective Memory Complaints Questionnaire (SMCQ-K). Scores range from 0 to 14, where higher scores indicate a higher level of subjective memory impairment.

Baseline and 10 weeks
Change in Pain Intensity (NPRS)
Zeitfenster: Baseline and 10 weeks

Pain intensity will be measured using the Numeric Pain Rating Scale (NPRS) for participants reporting pain. Scores range from 0 (no pain) to 10 (worst possible pain), where lower scores indicate reduced pain intensity.

Baseline and 10 weeks

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

1. November 2026

Primärer Abschluss (Geschätzt)

1. Februar 2027

Studienabschluss (Geschätzt)

1. Februar 2027

Studienanmeldedaten

Zuerst eingereicht

5. November 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

11. November 2026

Zuerst gepostet (Tatsächlich)

17. November 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

17. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

11. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • SYU 2026-09-027-002

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .